Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease.

Matsuzaki K, Ohsawa I, Nishitani T, Takeda Y, Inoshita H, Ishii M, Takagi M, Horikoshi S, Tomino Y.

J Nephrol. 2011 Mar-Apr;24(2):246-9.

PMID:
21240874
2.
3.

High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein.

Sakakima M, Fujigaki Y, Tsuji T, Fukasawa H, Miyaji T, Naito K, Yamamoto T, Yonemura K, Ohnishi K, Hishida A.

Intern Med. 2005 Sep;44(9):970-4.

4.
5.

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.

Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H.

Br J Haematol. 2004 Dec;127(5):543-51.

PMID:
15566357
6.

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

Sezer O, Schmid P, Shweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K.

Bone Marrow Transplant. 1999 May;23(9):967-9.

7.

High-dose therapy and autologous transplantation in amyloidosis-AL.

Majolino I, Marcenò R, Pecoraro G, Scimé R, Vasta S, Liberti G, Rizzo A, Indovina A, Caronia F.

Haematologica. 1993 Jan-Feb;78(1):68-71.

PMID:
8098314
8.

Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.

Petrakis I, Stylianou K, Mavroeidi V, Vardaki E, Stratigis S, Stratakis S, Xylouri I, Perakis C, Petraki C, Nakopoulou L, Daphnis E.

Nephrol Dial Transplant. 2010 Jun;25(6):2020-3. doi: 10.1093/ndt/gfq023. Epub 2010 Feb 3.

PMID:
20133281
9.

Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.

Kaposztas Z, Kahan BD, Katz SM, Van Buren CT, Cherem L.

Transplant Proc. 2009 Dec;41(10):4407-10. doi: 10.1016/j.transproceed.2009.10.005.

PMID:
20005409
10.

Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation.

Harada K, Akai Y, Sakan H, Yamaguchi Y, Nakatani K, Iwano M, Saito Y.

Clin Nephrol. 2010 Nov;74(5):384-8.

PMID:
20979947
11.

Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.

Matsuda M, Yamada T, Gono T, Shimojima Y, Ishii W, Fushimi T, Sakashita K, Koike K, Ikeda S.

Intern Med. 2005 May;44(5):428-33.

12.

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M.

Ann Intern Med. 2001 May 1;134(9 Pt 1):746-53.

PMID:
11329232
13.

Long-term outcome of autologous stem cell transplantation in light chain deposition disease.

Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N.

Nephrol Dial Transplant. 2008 Jun;23(6):2052-7. doi: 10.1093/ndt/gfm918. Epub 2008 Jan 4.

PMID:
18178602
14.
15.

[Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease].

Rekhtina IG, Mendeleeva LP, Stolyarevich ES, Galtseva IV, Povilaitite PE, Biryukova LS.

Ter Arkh. 2016;88(6):80-83. doi: 10.17116/terarkh201688680-83. Russian.

PMID:
27296267
16.

Diagnosis and monitoring a case of light-chain deposition disease in the kidney using a new, sensitive immunoassay.

Brockhurst I, Harris KP, Chapman CS.

Nephrol Dial Transplant. 2005 Jun;20(6):1251-3. Epub 2005 Mar 22. Erratum in: Nephrol Dial Transplant. 2005 Nov;20(11):2584.

PMID:
15784642
17.

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.

Witzens-Harig M, Waldherr R, Beimler J, Zeier M, Hansmann J, Ho AD, Goldschmidt H, Moehler T.

Ann Hematol. 2007 Dec;86(12):927-30. Epub 2007 Jun 29. No abstract available.

PMID:
17605010
18.

Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.

Mutluay R, Aki SZ, Erten Y, Konca C, Yagci M, Barit G, Sindel S.

Clin Nephrol. 2008 Dec;70(6):527-31.

PMID:
19049712
19.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Review.

PMID:
11842390
20.

Plasma cell dyscrasia with kappa light-chain crystals in proximal tubular cells: a histological, immunofluorescent, and ultrastructural study.

Cai G, Sidhu GS, Wieczorek R, Gu X, Herrera GA, Cubukcu-Dimopulo O, Kahn T.

Ultrastruct Pathol. 2006 Jul-Aug;30(4):315-9.

PMID:
16971357

Supplemental Content

Support Center